ROSSARI BIOTECH
|
ROSSARI BIOTECH Last 5 Year Financial Ratios History
[Consolidated]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 19.45 | 17.74 | 15.45 | 12.86 | 103.83 |
| CEPS(Rs) | 30.86 | 26.47 | 19.81 | 16.18 | 11.96 |
| DPS(Rs) | 0.50 | 0.50 | 0.50 | 0.50 | 5.00 |
| Book NAV/Share(Rs) | 165.29 | 145.65 | 78.31 | 56.39 | 281.39 |
| Tax Rate(%) | 25.63 | 28.31 | 25.08 | 25.71 | 27.94 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 12.85 | 11.84 | 17.21 | 17.37 | 15.01 |
| EBIT Margin(%) | 9.98 | 10.00 | 15.36 | 15.15 | 12.83 |
| Pre Tax Margin(%) | 8.64 | 9.15 | 14.94 | 14.56 | 12.27 |
| PAT Margin (%) | 6.43 | 6.56 | 11.19 | 10.82 | 8.84 |
| Cash Profit Margin (%) | 10.20 | 9.78 | 14.38 | 13.61 | 11.20 |
| Performance Ratios | |||||
| ROA(%) | 7.18 | 9.48 | 13.69 | 16.17 | 20.38 |
| ROE(%) | 12.52 | 16.17 | 23.11 | 31.83 | 41.88 |
| ROCE(%) | 18.48 | 24.37 | 28.81 | 37.93 | 54.40 |
| Asset Turnover(x) | 1.12 | 1.45 | 1.22 | 1.49 | 2.30 |
| Sales/Fixed Asset(x) | 2.31 | 3.18 | 4.01 | 5.78 | 5.94 |
| Working Capital/Sales(x) | 4.46 | 4.73 | 3.50 | 3.40 | 13.58 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.43 | 0.31 | 0.25 | 0.17 | 0.17 |
| Receivable days | 72.00 | 55.00 | 60.78 | 54.48 | 51.48 |
| Inventory Days | 41.37 | 34.95 | 39.17 | 34.21 | 31.80 |
| Payable days | 57.86 | 52.27 | 90.07 | 99.66 | 78.74 |
| Valuation Parameters | |||||
| PER(x) | 30.61 | 51.49 | 67.17 | - | - |
| PCE(x) | 19.29 | 34.51 | 52.38 | - | - |
| Price/Book(x) | 3.60 | 6.27 | 13.25 | - | - |
| Yield(%) | 0.08 | 0.05 | 0.05 | - | - |
| EV/Net Sales(x) | 1.95 | 3.36 | 7.47 | -0.08 | 0.01 |
| EV/Core EBITDA(x) | 14.15 | 25.51 | 40.08 | -0.46 | 0.04 |
| EV/EBIT(x) | 19.41 | 33.48 | 48.26 | -0.55 | 0.04 |
| EV/CE(x) | 2.06 | 3.52 | 8.22 | -0.10 | 0.01 |
| M Cap / Sales | 1.98 | 3.39 | 7.60 | - | - |
| Growth Ratio | |||||
| Net Sales Growth(%) | 11.66 | 109.06 | 18.21 | 16.25 | 76.91 |
| Core EBITDA Growth(%) | 16.92 | 47.78 | 21.92 | 38.25 | 70.32 |
| EBIT Growth(%) | 11.82 | 35.60 | 20.17 | 37.92 | 62.02 |
| PAT Growth(%) | 9.79 | 22.05 | 22.67 | 42.84 | 57.46 |
| EPS Growth(%) | 9.61 | 14.85 | 20.15 | -87.62 | 57.46 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.08 | 0.01 | - | 0.23 | 0.04 |
| Current Ratio(x) | 1.79 | 1.87 | 2.16 | 2.05 | 1.31 |
| Quick Ratio(x) | 1.39 | 1.35 | 1.62 | 1.71 | 0.86 |
| Interest Cover(x) | 7.46 | 11.77 | 36.71 | 25.70 | 23.03 |
| Total Debt/Mcap(x) | 0.02 | - | - | - | - |
Compare Financial Ratios of peers of ROSSARI BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ROSSARI BIOTECH | ₹4,009.5 Cr | -5.7% | 3.8% | 6.5% | Stock Analytics | |
| PIDILITE INDUSTRIES | ₹150,032.0 Cr | -1.1% | -3.3% | 23.6% | Stock Analytics | |
| SOLAR INDUSTRIES INDIA | ₹81,439.7 Cr | 2.5% | 3.2% | 132% | Stock Analytics | |
| SRF | ₹76,073.0 Cr | -2.7% | -2% | 5% | Stock Analytics | |
| GUJARAT FLUOROCHEMICALS | ₹39,348.3 Cr | -1.9% | 11.9% | 7.4% | Stock Analytics | |
| DEEPAK NITRITE | ₹33,339.9 Cr | -1.4% | 14.2% | 31.3% | Stock Analytics | |
ROSSARI BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ROSSARI BIOTECH | -5.7% |
3.8% |
6.5% |
| SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses
